Apoptosis, proliferation, and Fas (APO-I, CD95)/Fas ligand expression in medullary carcinoma of the breast

被引:0
|
作者
Yakirevich, E
Maroun, L
Cohen, O
Izhak, OB
Rennert, G
Resnick, MB
机构
[1] Lady Davis Carmel Med Ctr, Dept Pathol, IL-34362 Haifa, Israel
[2] Rambam Med Hosp, Dept Pathol, Haifa, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[4] Lady Davis Carmel Med Ctr, Dept Surg, IL-34362 Haifa, Israel
[5] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, IL-34362 Haifa, Israel
关键词
breast; medullary carcinoma; apoptosis; TUNEL; proliferation; PCNA; Fas; FasL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medullary carcinoma (MC) of the breast is a unique subtype of infiltrating ductal carcinoma that is characterized by a prominent lymphoid infiltrate and improved prognosis. Activated granzyme B+/CD8(+) cytotoxic T-lymphocytes (CTLs) infiltrating tumour cell nests constitute a major subset within the lymphoid infiltrate. As CTLs destroy target tumour cells by triggering apoptosis, it mould be of interest to determine whether the apoptotic rate in MC is increased. This study evaluates the extent of apoptosis in relation to Fas (APO-1, CD95)/Fas ligand (FasL) expression in MC. Fourteen cases of typical MC (TMC) and 15 cases of atypical MC (AMC) classified according to the Ridolfi criteria, as well as 19 cases of poorly differentiated infiltrating ductal carcinoma (PDC) were evaluated. The apoptotic index (AI) was assessed by the TUNEL method on paraffin-embedded tissue. Cell proliferation was evaluated immunohistochemically by PCNA staining. The level of Fas/FasL expression was determined semiquantitatively by immunohistochemistry using a four-grade scoring system. The AI was significantly increased in TMC and AMC as opposed to the PDC subgroup (2.2 +/- 0.8, 2.1 +/- 0.8, and 1.3 +/- 0.6, respectively; p < 0.05). A significant proportion (31.8 +/- 7.9% in TMC and 25.8 +/- 9.7% in AMC) of the apoptotic tumour cells within tumour nests mere in close contact with CD3(+) lymphocytes. Increased apoptosis was not accompanied by increased proliferation of tumour cells. The extent of Fas expression did not differ between the three subgroups. FasL was expressed both by tumour infiltrating lymphocytes in MC and by tumour epithelium in all three subgroups. The observation that the majority of MCs express Fas and are infiltrated by lymphocytes expressing FasL suggests that increased apoptosis in MC is mediated by Fas/FasL. However, our observation that the majority of MCs also express Fast and the fact that tumours co-expressing Fas and FasL did not show increased apoptosis suggest that there may be additional cytotoxic pathways that lead to tumour apoptosis in MC. Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 50 条
  • [31] The CD95(APO-1/Fas) DISC and beyond
    Peter, ME
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (01) : 26 - 35
  • [32] The CD95(APO-1/Fas) DISC and beyond
    M E Peter
    P H Krammer
    Cell Death & Differentiation, 2003, 10 : 26 - 35
  • [33] Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells
    Lee, TB
    Min, YD
    Lim, SC
    Kim, KJ
    Jeon, HJ
    Choi, SM
    Choi, CH
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (01) : 32 - 38
  • [34] Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: Relationship with neuronal cell death and inflammatory mediators
    Grosjean, M. B.
    Lenzlinger, P. M.
    Stahel, P. F.
    Yatsiv, I.
    Shohami, E.
    Trentz, O.
    Kossmann, T.
    Morganti-Kossmann, M. C.
    HISTOLOGY AND HISTOPATHOLOGY, 2007, 22 (03) : 235 - 250
  • [35] Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors - Implications for immune privilege and immune escape
    Bernstorff, WV
    Glickman, JN
    Odze, RD
    Farraye, FA
    Joo, HG
    Goedegebuure, PS
    Eberlein, TJ
    CANCER, 2002, 94 (10) : 2552 - 2560
  • [36] CD95/Fas ligand mRNA is toxic to cells
    Putzbach, Will
    Haluck-Kangas, Ashley
    Gao, Quan Q.
    Sarshad, Aishe A.
    Bartom, Elizabeth T.
    Stults, Austin
    Qadir, Abdul S.
    Hafner, Markus
    Peter, Marcus E.
    ELIFE, 2018, 7
  • [37] The CD95(APO-1/Fas)/CD95L system
    Krammer, PH
    TOXICOLOGY LETTERS, 1998, 103 : 131 - 137
  • [38] Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system
    Mariani, SM
    Matiba, B
    Sparna, T
    Krammer, PH
    JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 193 (01) : 63 - 70
  • [39] Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity
    Shimizu, M
    Fontana, A
    Takeda, Y
    Yoshimoto, T
    Tsubura, A
    Matsuzawa, A
    CELLULAR IMMUNOLOGY, 2001, 207 (01) : 41 - 48
  • [40] Apoptosis of bovine granulosa cells after serum withdrawal is mediated by Fas antigen (CD95) and Fas ligand
    Hu, CL
    Cowan, RG
    Harman, RM
    Porter, DA
    Quirk, SM
    BIOLOGY OF REPRODUCTION, 2001, 64 (02) : 518 - 526